跳至主要内容
临床试验/NCT06191523
NCT06191523已完成不适用

The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis (Review of Malondialdehyde, Interleukin-6, Interleukin-8, Absolute Neutrophil Counts, and Sepsis Score)

Universitas Sebelas Maret1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2023年4月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
42
试验地点
1
主要终点
Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System

研究概览

简要总结

The goal of this clinical trial is to assess the effect of melatonin on MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis. The main question aim to answer :

• Does melatonin affect MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis?

The participants in the treatment group will receive a single dose of oral melatonin 20 mg, meanwhile those the control group will receive placebo.

The researchers will compare MDA serum, IL-6, IL-8 levels, ANC, and sepsis score before and after receiving melatonin, whether there are decreases of MDA serum, IL-6, IL-8 levels, ANC and increase of sepsis score

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
28 Weeks 至 36 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Newborns with gestational age of 28-36+6 weeks, birth weight according to gestational age, and diagnosis of sepsis based on HPS and PRS sepsis score criteria

排除标准

  • Major congenital anomalies of the gastrointestinal tract.
  • Continuous vomiting.
  • Newborns with hypoxic ischemic encephalopathy (HIE), intracranial hemorrhage, feeding intolerance, necrotizing enterocolitis (NEC) and hormonal disorders.
  • Septic shock.

研究组 & 干预措施

Control Group

Placebo Comparator

The control group will receive standard therapy and placebo.

干预措施: Control Group (Other)

Control Group

Placebo Comparator

The control group will receive standard therapy and placebo.

干预措施: Treatment Group (Drug)

Treatment Group

Experimental

The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg

干预措施: Control Group (Other)

Treatment Group

Experimental

The participants in the treatment group will receive standard therapy and a single dose of oral melatonin 20 mg

干预措施: Treatment Group (Drug)

结局指标

主要结局

Number of Participants with Treatment-Related Improvement of Sepsis Score Based on Gitto Scoring System

时间窗: From enrollment to the end of treatment at 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dwi Hidayah

Doctoral Program

Universitas Sebelas Maret

研究点 (1)

Loading locations...

相似试验

The Effect of Melatonin as an Adjuvant Therapy for... | 临床试验